Enhanced anandamide degradation is associated with neuronal apoptosis induced by the HIV-1 coat glycoprotein gp120 in the rat neocortex

Journal of Neurochemistry

Volumn 89, Issue 5, 2004, Pages 1293-1300

  Maccarrone, Mauro ^a,b   Piccirilli, Silvia ^b   Battista, Natalia ^c   Del Duca, Claudio ^b   Nappi, Giuseppe ^b   Corasaniti, M Tiziana ^d   Finazzi Agrò, Alessandro ^c   Bagetta, Giacinto ^b,e  

^a UNIVERSITY OF TERAMO   (Italy)

^b C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^e Calabria University at Cosenza   (Italy)

Author keywords

Endocannabinoids; Gp120; Lipoxygenase; Neuronal apoptosis

Indexed keywords

ANANDAMIDE; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID DERIVATIVE; BOVINE SERUM ALBUMIN; CANNABINOID; CARRIER PROTEIN; COAT PROTEIN; FATTY ACID AMIDASE; FLUORINE DERIVATIVE; GLYCOPROTEIN GP 120; METHYLARACHIDONOYL FLUOROPHOSPHONATE; PHOSPHOLIPASE D; PHOSPHONIC ACID DERIVATIVE; RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DEGRADATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HIPPOCAMPUS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOREACTIVITY; MALE; NEOCORTEX; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; TIME;

AMIDOHYDROLASES; ANIMALS; APOPTOSIS; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACIDS; CARRIER PROTEINS; ENZYME INHIBITORS; HIV ENVELOPE PROTEIN GP120; INJECTIONS, INTRAVENTRICULAR; MALE; NEOCORTEX; NEURONS; PHOSPHONIC ACIDS; POLYUNSATURATED ALKAMIDES; RATS; RATS, WISTAR;

ANIMALIA; BOVINAE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 2642514672     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02430.x     Document Type: Article

References (42)

1. Bagetta G., Corasaniti M. T., Berliocchi L., Navarra M., Finazzi-Agrò A. and Nisticò G. (1995) HIV-1 gp120 produces DNA fragmentation in the cerebral cortex of rat. Biochem. Biophys. Res. Commun. 211, 130-136.
2. Bagetta G., Corasaniti M. T., Aloe L., Berliocchi L., Costa N., Finazzi-Agrò A. and Nisticò. G. (1996a) Intracerebral injection of human immunodeficiency virus type 1 coat protein gp120 differentially affects the expression of nerve growth factor and nitric oxide synthase in the hippocampus of rat. Proc. Natl Acad. Sci. USA 93, 928-933.
3. Bagetta G., Corasaniti M. T., Malorni W., Rainaldi G., Costa N., Berliocchi L., Finazzi-Agrò A. and Nisticò G. (1996b) The HIV-1 gp120 causes ultrastructural changes typical of apoptosis in the rat cerebral cortex. Neuroreport 7, 1722-1724.
4. Bagetta G., Corasaniti M. T., Paoletti A. M., Berliocchi L., Nisticò R., Giammarioli A. M., Malorni W. and Finazzi-Agrò A. (1998) HIV-1 gp120-induced apoptosis in the rat neocortex involves enhanced expression of cyclooxygenase type 2 (COX-2). Biochem. Biophys. Res. Commun. 244, 819-824.
5. Bagetta G., Corasaniti M. T., Berliocchi L., Nisticò R., Giammarioli A. M., Malorni W., Aloe L. and Finazzi-Agrò A. (1999) Involvement of interleukin-1β in the mechanism of human immunodeficiency virus type 1 (HIV-1) recombinant protein gp120-induced apoptosis in the neocortex of rat. Neuroscience 89, 1051-1066.
6. Bezzi P., Carmignoto G., Pasti L., Vesce S., Rossi D., Rizzini B. L., Pozzan T. and Volterra A. (1998) Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 391, 281-285.
7. Bisogno T., De Petrocellis L. and Di Marzo V. (2002) Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications. Curr. Pharm. Des. 8, 533-547.
8. Bracey M. H., Hanson M. A., Masuda K. R., Stevens R. C. and Cravatt B. F. (2002) Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling. Science 298, 1793-1796.
9. Catani M. V., Corasaniti M. T., Ranalli M., Amantea D., Litovchick A., Lapidot A. and Melino G. (2003) The Tat antagonist neomycin B hexa-arginine conjugate inhibits gp-120-induced death of human neuroblastoma cells. J. Neurochem. 84, 1237-1245.
10. Corasaniti M. T., Maccarrone M., Strongoli M. C., Navarra M., Colica C., Rotiroti D. and Bagetta G. (1999) Apoptosis induced by gp120 in the brain cortex of rat is minimized by the 21-aminosteroid, U74389G, and by NMDA receptor antagonists. Pharmacol. Res. 39, 34.
11. Corasaniti M. T., Maccarrone M., Nisticò R., Malomi W., Retired D. and Bagetta G. (2001a) Exploitation of the HIV-1 coat glycoprotein, gp120, in neurodegenerative studies in vivo. J. Neurochem. 79, 1-8.
12. Corasaniti M. T., Turano P., Bilotta A., Malomi W., Stringaro A. R., Nisticò R., Finazzi-Agrò A. and Bagetta G. (2001b) Evidence that increases of mitochondrial immunoreactive IL-1β by HIV-1 gp120 implicate in situ cleavage of pro-IL-1β in the neocortex of rat. J. Neurochem. 78, 611-618.
13. Cravatt B. F., Demarest K., Patricelli M. P., Bracey M. H., Giang D. K., Martin B. R. and Lichtman A. H. (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl Acad. Sci. USA 98, 9371-9376.
14. De Petrocellis L., Bisogno T., Maccarrone M., Davis J. B., Finazzi-Agrò A. and Di Marzo V. (2001) The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J Biol. Chem. 276, 12856-12863.
15. Deutsch D. G., Glaser S. T., Howell J. M., Kunz J. S., Puffenbarger R. A., Hillard C. J. and Abumrad N. (2001) The cellular uptake of anandamide is coupled to its breakdown by fatty acid amide hydrolase (FAAH). J. Biol. Chem. 276, 6967-6973.
16. Di Marzo V., De Petrocellis L., Fezza F., Ligresti A. and Bisogno T. (2002) Anandamide receptors. Prostaglandins Leukot. Essent. Fatty Acids 66, 377-391.
17. Esposito G., Ligresti A., Izzo A. A., Bisogno T., Ruvo M., Di Rosa M., Di Marzo V. and Iuvone T. (2002) The endocannabinoid system protects rat glioma cells against HIV-1 Tat protein-induced cytotoxicity. Mechanism and regulation. J. Biol. Chem. 277, 50348-50354.
18. Genis P., Jett M., Bernton E. W. et al. (1992) Cytokines and arachidonic acid metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J. Exp. Med. 176, 1703-1718.
19. Giang D. K. and Cravatt B. F. (1997) Molecular characterization of human and mouse fatty acid amide hydrolase. Proc. Natl Acad. Sci. USA 94, 2238-2242.
20. Glaser S. T., Abumrad N. A., Fatade F., Kaczocha M., Studholme K. M. and Deutsch D. G. (2003) Evidence against the presence of an anandamide transporter. Proc. Natl Acad. Sci. USA 100, 4269-4274.
21. Gubellini P., Picconi B., Bari M., Battista N., Calabresi P., Centonze D., Bernardi G., Finazzi-Agrò A. and Maccarrone M. (2002) Experimental Parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. J Neurosci. 22, 6900-6907.
22. Guzman M., Sanchez C. and Galve-Roperh I. (2002) Cannabinoids and cell fate. Pharmacol. Ther. 95, 175-184.
23. Hansen H. S., Moesgaard B., Hansen H. H. and Petersen G. (2000) N-Acylethanolamines and precursor phospholipids: relation to cell injury. Chem. Phys. Lipids 108, 135-150.
24. Hill J. M., Mervis R. F., Avidor R., Moody T. W. and Brenneman D. E. (1993) HIV envelope protein-induced neuronal damage and retardation of behavioural development in rat neonates. Brain Res. 603, 222-233.
25. Hillard C. J. and Jarrahian A. (2000) The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes. Chem. Phys. Lipids 108, 123-134.
26. Hillard C. J. and Jarrahian A. (2003) Cellular accumulation of anandamide: consensus and controversy. Br. J. Pharmacol. 140, 802-808.
27. Jakobsson P.-J., Steinhilber D., Odlander B., Radmark O., Claesson H.-E. and Samuelsson B. (1992) On the expression and regulation of 5-lipoxygenase in human lymphocytes. Proc. Natl Acad. Sci. USA 89, 3521-3525.
28. Jordt S. E. and Julius D. (2002) Molecular basis for species-specific sensitivity to 'hot' chili peppers. Cell 108, 421-430.
29. Maccarrone M. and Finazzi-Agrò A. (2003) The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis. Cell Death Differ. 10, 946-955.
30. Maccarrone M., Bari M., Corasaniti M. T., Nisticò R., Bagetta G. and Finazzi-Agrò A. (2000a) HIV-1 coat glycoprotein gp120 induces apoptosis in rat brain neocortex by deranging the arachidonate cascade in favour of prostanoids. J. Neurochem. 75, 196-203.
31. Maccarrone M., Lorenzon T., Bari M., Melino G. and Finazzi-Agrò A. (2000b) Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. J. Biol. Chem. 275, 31938-31945.
32. Maccarrone M., Gubellini P., Bari M., Picconi B., Centonze D., Bernardi G., Finazzi-Agrò A. and Calabresi P. (2003) Levodopa treatment reverses endocannabinoid system abnormalities in experimental Parkinsonism. J. Neurochem. 85, 1018-1025.
33. Marsicano G., Goodenough S., Monory K. et al. (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302, 84-88.
34. Mechoulam R., Panikashvili D. and Shohami E. (2002) Cannabinoids and brain injury: therapeutic implications. Trends Mol. Med. 8, 58-61.
35. 31P NMR and enzyme activity study. J. Lipid. Res. 41, 985-990.
36. Okamoto Y., Morishita J., Tsuboi K., Tonai T. and Ueda N. (2004) Molecular characterization of a phospholipase D generating anandamide and its congeners. J. Biol. Chem. 274, 5298-5305.
37. Paxinos G. and Watson C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
38. Pertwee R. G. (1999) Pharmacology of cannabinoid receptor ligands. Curr. Med. Chem. 6, 635-664.
39. Schmid P. C., Wold L. E., Krebsbach R. J., Berdyshev E. V. and Schmid H. H. O. (2002) Anandamide and the other N-acylethanolamines in human tumors. Lipids 37, 907-912.
40. Sugiura T., Kobayashi Y., Oka S. and Waku K. (2002) Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins Leukot. Essent. Fatty Acids 66, 173-192.
41. Van der Stelt M., Veldhuis W. B., Maccarrone M., Nicolay K., Veldink G. A., Di Marzo V. and Vliegenthart J. F. G. (2002a) Acute neuronal injury, excitotoxicity and the endocannabinoid system. Mol. Neurobiol. 26, 317-346.
42. Van der Stelt M., van Kuik J. A., Bari M., van Zadelhoff G., Leeflang B. R., Veldink G. A., Finazzi-Agrò A., Vliegenthart J. F. G. and Maccarrone M. (2002b) Oxygenated metabolites of anandamide and 2-arachidonoyl-glycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter and fatty acid amide hydrolase. J. Med. Chem. 45, 3709-3720.